• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Quixnet Email
  • Quixnet Downloads
  • Dial up locations
  • User Agreement

Welcome to Quixnet

  • Breaking News
  • World
  • US
  • Business
  • Sports
  • Technology

Gilead cancer immunotherapy wins US approval with $373000 price

October 17, 2017 by quixnet

  1. Gilead cancer immunotherapy wins US approval with $373000 priceNasdaq
  2. The FDA just approved a revolutionary gene-modification treatmentQuartz
  3. Kite Nabs First Adult CAR-T Approval With Notable Uptick Of CuresXconomy
  4. UPDATED: FDA follows through with a groundbreaking OK for Yescarta, Gilead’s new CAR-T breakthroughEndpoints News
  5. Cutting-edge immunotherapy treatment approved for another deadly cancerWashington Post
  6. Full coverage

Filed Under: Business

Primary Sidebar

Quote of the Day

Everything you’ve ever wanted is on the other side of fear.
George Addair

this day in history


Footer

Read More

  • Breaking News
  • World
  • US
  • Business
  • Sports
  • Technology

My Account & Help

  • Quixnet Email
  • Quixnet Downloads
  • Dial up locations
  • User Agreement

Contact

  • Billing: 1-855-324-8915
  • Support: 1-877-244-8996
  • support@quixnet.net
  • Contact Us

Copyright © 2021 · Urban Communications Inc. · Log in